Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease
Elena Barengolts, Stefan J. Green, Yuval Eisenberg, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0194171-e0194171
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Role of gut microbiota in type 2 diabetes pathophysiology
Manoj Gurung, Zhipeng Li, Hannah You, et al.
EBioMedicine (2020) Vol. 51, pp. 102590-102590
Open Access | Times Cited: 1343
Gut microbiota in patients with obesity and metabolic disorders — a systematic review
Zhilu Xu, Wei Jiang, Wenli Huang, et al.
Genes & Nutrition (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 135
Mining microbes for mental health: Determining the role of microbial metabolic pathways in human brain health and disease
Simon Spichak, Thomaz F. S. Bastiaanssen, Kirsten Berding, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 698-761
Open Access | Times Cited: 106
Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation
Lili Su, Zhifan Hong, Tong Zhou, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78
<p>Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus</p>
Qi Zhang, Nan Hu
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 5003-5014
Open Access | Times Cited: 130
A potential role for the gut microbiome in substance use disorders
Katherine Meckel, Drew D. Kiraly
Psychopharmacology (2019) Vol. 236, Iss. 5, pp. 1513-1530
Open Access | Times Cited: 127
Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome
Li Zhang, Jingjing Meng, Yuguang Ban, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 27, pp. 13523-13532
Open Access | Times Cited: 121
Metformin and gut microbiota: their interactions and their impact on diabetes
Natalia G. Vallianou, Theodora Stratigou, Stylianos Tsagarakis
HORMONES (2019) Vol. 18, Iss. 2, pp. 141-144
Closed Access | Times Cited: 115
Metabolic Effects of Oxytocin
Shana E. McCormack, James E. Blevins, Elizabeth A. Lawson
Endocrine Reviews (2019) Vol. 41, Iss. 2, pp. 121-145
Open Access | Times Cited: 110
Intestinal AMPK modulation of microbiota mediates crosstalk with brown fat to control thermogenesis
Eryun Zhang, Lihua Jin, Yangmeng Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain
Zoltán Zádori, Kornél Király, Mahmoud Al‐Khrasani, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108327-108327
Open Access | Times Cited: 47
Effects of metformin on the gut microbiota: A systematic review
Pavlo Petakh, Iryna Kamyshna, Oleksandr Kamyshnyi
Molecular Metabolism (2023) Vol. 77, pp. 101805-101805
Open Access | Times Cited: 31
Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use
Udhghatri Kolli, Richa Jalodia, Shamsudheen Moidunny, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 24
Combing fecal microbial community data to identify consistent obesity-specific microbial signatures and shared metabolic pathways
Yu Lin, Zhilu Xu, Yun Kit Yeoh, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106476-106476
Open Access | Times Cited: 22
Bridging the gap: associations between gut microbiota and psychiatric disorders
Gellan K. Ahmed, Haidi Karam‐Allah Ramadan, Khaled Elbeh, et al.
Middle East Current Psychiatry (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 8
The role of morphine‐ and fentanyl‐induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota‐gut‐brain axis
Karan H. Muchhala, Prajkta Kallurkar, Minho Kang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 8
Open Access | Times Cited: 8
Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity
Angélica Cruz-Lebrón, Ramona Johnson, Claire Mazahery, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 55
The combined effects of probiotics and restricted calorie diet on the anthropometric indices, eating behavior, and hormone levels of obese women with food addiction: a randomized clinical trial
Elham Narmaki, Mohaddeseh Borazjani, Asal Ataie‐Jafari, et al.
Nutritional Neuroscience (2020) Vol. 25, Iss. 5, pp. 963-975
Closed Access | Times Cited: 50
Blood-Glucose-Lowering Effect of Coptidis Rhizoma Extracts From Different Origins via Gut Microbiota Modulation in db/db Mice
Yuanfeng Lyu, Lin Lin, Yuning Xie, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 48
Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword
Pavlo Petakh, Iryna Kamyshna, Andriy Nykyforuk, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 477-477
Open Access | Times Cited: 30
Effect of cinnamon spice on continuously monitored glycemic response in adults with prediabetes: a 4-week randomized controlled crossover trial
Hila Zelicha, Jieping Yang, Susanne M. Henning, et al.
American Journal of Clinical Nutrition (2024) Vol. 119, Iss. 3, pp. 649-657
Open Access | Times Cited: 6
Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment
Rachel E. Gicquelais, Amy M. Bohnert, Laura Thomas, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 46
Opioid system influences gut-brain axis: Dysbiosis and related alterations
Lola Rueda‐Ruzafa, Francisco Cruz, Diana Cardona, et al.
Pharmacological Research (2020) Vol. 159, pp. 104928-104928
Closed Access | Times Cited: 44
Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies
Thao T. B. Cao, Kun‐Chang Wu, Jye‐Lin Hsu, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 40
Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice
Ana C. Thomaz, Vishakh Iyer, Taylor J. Woodward, et al.
Experimental Neurology (2021) Vol. 343, pp. 113787-113787
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top